相关实验视频
Updated: Sep 14, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
在2型糖尿病中使用连续皮下胰岛素输注或每天多次注射时,影响胰岛素需求的因素
Ruo-Man Sun1, De-Xing Dai1, Feng Xu1
1National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory of Metabolic Bone Disease, and Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan Province, China.
接受连续皮下胰岛素输注 (CSII) 的2型糖尿病 (T2DM) 患者需要的胰岛素比使用多次每日注射 (MDI) 的患者少. 体重指数,腰围和葡萄糖水平都会影响两组人群的胰岛素剂量.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 已知持续的皮下胰岛素输注 (CSII) 可以降低1型糖尿病患者的胰岛素剂量.
- 在2型糖尿病 (T2DM) 中,CSII与多次每日注射 (MDI) 的相对胰岛素需求仍然不清楚.
研究的目的:
- 为了在T2DM患者中比较CSII和MDI疗法之间的胰岛素剂量需求.
- 确定影响CSII和MDIT2DM治疗方式中胰岛素需求的因素.
主要方法:
- 一组954名T2DM患者被分为CSII和MDI组.
- 总每日胰岛素剂量 (TDD),每公斤的TDD和基础胰岛素比率进行了比较.
- 对两个治疗组分析了影响胰岛素剂量的因素.
主要成果:
- 与CSII组相比,MDI组的TDD,TDD/kg和%TBa显著更高.
- 在两组中,TDD的增加独立地与更高的体重指数 (BMI),腰围 (WC),禁食血葡萄糖 (FPG) 和糖化血红蛋白 (HbA1c) 相关.
结论:
- 与MDI相比,接受CSII的T2DM患者需要较低的胰岛素剂量来实现最佳的血糖控制.
- 在T2DM患者中,BMI,WC,FPG和HbA1c是胰岛素剂量的关键决定因素,不论其输送方法如何.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
One-Compartment Model: IV Infusion
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...

